From left, Duke University School of Medicine researchers Susan K. Murphy, PhD; Andrew Berchuck, MD; Yasaman Setayeshpour, PhD.; and Jen-Tsan Ashley Chi, Ph.D.
Duke researchers show that fluid buildup fuels tumor growth and that an existing cholesterol drug could help strip away that advantage.
Jen-Tsan Ashley Chi, PhD, and Yasaman Setayeshpour, PhD, working with gynecologic oncologist Andrew Berchuck, MD, lay out a strategy that targets not just the tumor but the environment it depends on.